Kevin Waters insider trades: PROCEPT BioRobotics (PRCT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kevin reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | PRCT | ↓ Sell | 357 | $28.48 | $10K | Direct | Jun 10, 2026 (2d) |
| Mar 17, 2026 | PRCT | ↓ Sell | 706 | $28.15 | $20K | Direct | Mar 19, 2026 (2d) |
| Mar 6, 2026 | PRCT | ↓ Sell | 6,721 | $23.70 | $159K | Direct | Mar 9, 2026 (3d) |
| Mar 18, 2025 | PRCT | ↓ Sell | 733 | $57.06 | $42K | Direct | Mar 19, 2025 (1d) |
| Mar 6, 2025 | PRCT | ↓ Sell | 3,662 | $61.31 | $225K | Direct | Mar 10, 2025 (4d) |
| Oct 15, 2024 | PRCT | ↓ Sell | 25,000 | $72.47 | $1.8M | Direct | Oct 17, 2024 (2d) |
| Sep 16, 2024 | PRCT | ↓ Sell | 25,000 | $82.51 | $2.1M | Direct | Sep 18, 2024 (2d) |
| Mar 18, 2024 | PRCT | ↓ Sell | 1,024 | $48.83 | $50K | Direct | Mar 20, 2024 (2d) |
| Mar 6, 2024 | PRCT | ↓ Sell | 3,435 | $46.67 | $160K | Direct | Mar 7, 2024 (1d) |
| Feb 12, 2024 | PRCT | ↓ Sell | 22,349 | $50.16 | $1.1M | Direct | Feb 13, 2024 (1d) |
| Feb 9, 2024 | PRCT | ↓ Sell | 29,581 | $50.09 | $1.5M | Direct | Feb 9, 2024 (0d) |
| Jan 9, 2024 | PRCT | ↓ Sell | 17,310 | $45.07 | $780K | Direct | Jan 11, 2024 (2d) |
| Dec 13, 2023 | PRCT | ↓ Sell | 71,465 | $40.05 | $2.9M | Direct | Dec 15, 2023 (2d) |
| Dec 8, 2023 | PRCT | ↓ Sell | 15,085 | $40.01 | $604K | Direct | Dec 8, 2023 (0d) |
| Jun 15, 2023 | PRCT | ↓ Sell | 22,631 | $35.12 | $795K | Direct | Jun 15, 2023 (0d) |
| Mar 16, 2023 | PRCT | ↓ Sell | 706 | $31.84 | $22K | Direct | Mar 17, 2023 (1d) |
| Mar 8, 2023 | PRCT | ↓ Sell | 30,000 | $34.33 | $1.0M | Direct | Mar 9, 2023 (1d) |
| Jul 3, 2018 | ARAY | ↓ Sell | 14,265 | $4.08 | $58K | Direct | Jul 3, 2018 (0d) |
| Apr 3, 2018 | ARAY | ↓ Sell | 2,997 | $4.65 | $14K | Direct | Apr 3, 2018 (0d) |
| Dec 1, 2017 | ARAY | ↓ Sell | 7,154 | $5.06 | $36K | Direct | Dec 1, 2017 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PRCT insiders
Open-market trades in the last 12 months
About Kevin Waters's insider trades
Kevin Waters is EVP, CFO at PROCEPT BioRobotics (PRCT). Since Dec 1, 2017, Kevin has reported no open-market purchases and 20 sales worth $13.3M on SEC Form 4. In the last 12 months: 3 sales ($189K).
Their filings also include grants and awards (13 filings), shares withheld for taxes (11 filings), option exercises (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PRCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.